British Journal of Cancer - AOP - nature.com science feeds The BJC is owned by Cancer Research UK, a charity dedicated to understanding the causes, prevention and treatment of cancer and to making sure that the best new treatments reach patients in the clinic as quickly as possible. The journal reflects these aims. It was founded more than fifty years ago and, from the start, its far-sighted mission was to encourage communication of the very best cancer research from laboratories and clinics in all countries. The breadth of its coverage, its editorial independence and it consistent high standards, have made BJC one of the world's premier general cancer journals. Its increasing popularity is reflected by a steadily rising impact factor. http://www.nature.com/bjc/journal/vaop/ncurrent/rss.rdf Nature Publishing Group en Copyright © Cancer Research UK British Journal of Cancer 0007-0920 Copyright © Cancer Research UK permissions@nature.com British Journal of Cancer http://www.nature.com/aj/images/logos_b_o_w/bjc.gif http://www.nature.com/bjc/ Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events http://feeds.nature.com/~r/bjc/rss/aop/~3/tAZSoWbTgnw/sj.bjc.6605255 Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events

British Journal of Cancer advance online publication, September 29, 2009. doi:10.1038/sj.bjc.6605255

Authors: M Aapro, B Osterwalder, A Scherhag & H U Burger

]]> Epoetin-β treatment in patients with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target haemoglobin levels on survival, tumour progression and thromboembolic events M Aapro B Osterwalder A Scherhag H U Burger doi:10.1038/sj.bjc.6605255 British Journal of Cancer advance online publication, September 29, 2009 2009-07-29 British Journal of Cancer September 29, 2009 10.1038/sj.bjc.6605255 http://dx.doi.org/10.1038/sj.bjc.6605255 aop current http://dx.doi.org/10.1038/sj.bjc.6605255 COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/pFrKardUEng/sj.bjc.6605338 COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605338

Authors: I P M Tomlinson, M Dunlop, H Campbell, B Zanke, S Gallinger, T Hudson, T Koessler, P D Pharoah, I Niittymäkix, S Tuupanenx, L A Aaltonen, K Hemminki, A Lindblom, A Försti, O Sieber, L Lipton, T van Wezel, H Morreau, J T Wijnen, P Devilee, K Matsuda, Y Nakamura, S Castellví-Bel, C Ruiz-Ponte, A Castells, A Carracedo, J W C Ho, P Sham, R M W Hofstra, P Vodicka, H Brenner, J Hampe, C Schafmayer, J Tepel, S Schreiber, H Völzke, M M Lerch, C A Schmidt, S Buch, V Moreno, C M Villanueva, P Peterlongo, P Radice, M M Echeverry, A Velez, L Carvajal-Carmona, R Scott, S Penegar, P Broderick, A Tenesa & R S Houlston

]]> COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer I P M Tomlinson M Dunlop H Campbell B Zanke S Gallinger T Hudson T Koessler P D Pharoah I Niittymäkix S Tuupanenx L A Aaltonen K Hemminki A Lindblom A Försti O Sieber L Lipton T van Wezel H Morreau J T Wijnen P Devilee K Matsuda Y Nakamura S Castellví-Bel C Ruiz-Ponte A Castells A Carracedo J W C Ho P Sham R M W Hofstra P Vodicka H Brenner J Hampe C Schafmayer J Tepel S Schreiber H Völzke M M Lerch C A Schmidt S Buch V Moreno C M Villanueva P Peterlongo P Radice M M Echeverry A Velez L Carvajal-Carmona R Scott S Penegar P Broderick A Tenesa R S Houlston doi:10.1038/sj.bjc.6605338 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605338 http://dx.doi.org/10.1038/sj.bjc.6605338 aop current http://dx.doi.org/10.1038/sj.bjc.6605338 The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy http://feeds.nature.com/~r/bjc/rss/aop/~3/XvBWV_0AYcM/sj.bjc.6605349 The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy

British Journal of Cancer advance online publication, October 6, 2009. doi:10.1038/sj.bjc.6605349

Authors: J Griggs & K Zinkewich-Peotti

]]> The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapy J Griggs K Zinkewich-Peotti doi:10.1038/sj.bjc.6605349 British Journal of Cancer advance online publication, October 6, 2009 2009-10-06 British Journal of Cancer October 6, 2009 10.1038/sj.bjc.6605349 http://dx.doi.org/10.1038/sj.bjc.6605349 aop current http://dx.doi.org/10.1038/sj.bjc.6605349 Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI http://feeds.nature.com/~r/bjc/rss/aop/~3/3RSTMOsQnng/sj.bjc.6605367 Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605367

Authors: T Minowa, K Kawano, H Kuribayashi, K Shiraishi, T Sugino, Y Hattori, M Yokoyama & Y Maitani

]]> Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI T Minowa K Kawano H Kuribayashi K Shiraishi T Sugino Y Hattori M Yokoyama Y Maitani doi:10.1038/sj.bjc.6605367 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605367 http://dx.doi.org/10.1038/sj.bjc.6605367 aop current http://dx.doi.org/10.1038/sj.bjc.6605367 Brain metastases admissions in Sweden between 1987 and 2006 http://feeds.nature.com/~r/bjc/rss/aop/~3/xBIqJCxK0_U/sj.bjc.6605373 Brain metastases admissions in Sweden between 1987 and 2006

British Journal of Cancer advance online publication, October 13, 2009. doi:10.1038/sj.bjc.6605373

Authors: K E Smedby, L Brandt, M L Bäcklund & P Blomqvist

]]> Brain metastases admissions in Sweden between 1987 and 2006 K E Smedby L Brandt M L Bäcklund P Blomqvist doi:10.1038/sj.bjc.6605373 British Journal of Cancer advance online publication, October 13, 2009 2009-10-13 British Journal of Cancer October 13, 2009 10.1038/sj.bjc.6605373 http://dx.doi.org/10.1038/sj.bjc.6605373 aop current http://dx.doi.org/10.1038/sj.bjc.6605373 Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth http://feeds.nature.com/~r/bjc/rss/aop/~3/tQPx9MzIFRI/sj.bjc.6605376 Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605376

Authors: A M Traish & A Morgentaler

]]> Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth A M Traish A Morgentaler doi:10.1038/sj.bjc.6605376 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605376 http://dx.doi.org/10.1038/sj.bjc.6605376 aop current http://dx.doi.org/10.1038/sj.bjc.6605376 Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials http://feeds.nature.com/~r/bjc/rss/aop/~3/klPgklHVVO0/sj.bjc.6605377 Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605377

Authors: A D Wagner, P Buechner-Steudel, M Moehler, H Schmalenberg, R Behrens, J Fahlke, A Wein, S Behl, O Kuss, G Kleber & W E Fleig

]]> Gemcitabine, oxaliplatin and 5-FU in advanced bile duct and gallbladder carcinoma: two parallel, multicentre phase-II trials A D Wagner P Buechner-Steudel M Moehler H Schmalenberg R Behrens J Fahlke A Wein S Behl O Kuss G Kleber W E Fleig doi:10.1038/sj.bjc.6605377 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605377 http://dx.doi.org/10.1038/sj.bjc.6605377 aop current http://dx.doi.org/10.1038/sj.bjc.6605377 Assessment of breast cancer opportunistic screening by clinical–pathological indicators: a population-based study http://feeds.nature.com/~r/bjc/rss/aop/~3/6h5qEhsKXDE/sj.bjc.6605378 Assessment of breast cancer opportunistic screening by clinical–pathological indicators: a population-based study

British Journal of Cancer advance online publication, October 27, 2009. doi:10.1038/sj.bjc.6605378

Authors: A Bordoni, N M Probst-Hensch, L Mazzucchelli & A Spitale

]]> Assessment of breast cancer opportunistic screening by clinical–pathological indicators: a population-based study A Bordoni N M Probst-Hensch L Mazzucchelli A Spitale doi:10.1038/sj.bjc.6605378 British Journal of Cancer advance online publication, October 27, 2009 2009-10-27 British Journal of Cancer October 27, 2009 10.1038/sj.bjc.6605378 http://dx.doi.org/10.1038/sj.bjc.6605378 aop current http://dx.doi.org/10.1038/sj.bjc.6605378 Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease http://feeds.nature.com/~r/bjc/rss/aop/~3/tR13dxvDwYA/sj.bjc.6605379 Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605379

Authors: S Darby, T Murphy, H Thomas, C N Robson, H Y Leung, M E Mathers & V J Gnanapragasam

]]> Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease S Darby T Murphy H Thomas C N Robson H Y Leung M E Mathers V J Gnanapragasam doi:10.1038/sj.bjc.6605379 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605379 http://dx.doi.org/10.1038/sj.bjc.6605379 aop current http://dx.doi.org/10.1038/sj.bjc.6605379 Family history and the risk of gastric cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/1M68-Qsr0i0/sj.bjc.6605380 Family history and the risk of gastric cancer

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605380

Authors: M Yaghoobi, R Bijarchi & S A Narod

]]> Family history and the risk of gastric cancer M Yaghoobi R Bijarchi S A Narod doi:10.1038/sj.bjc.6605380 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605380 http://dx.doi.org/10.1038/sj.bjc.6605380 aop current http://dx.doi.org/10.1038/sj.bjc.6605380 A prospective study of lifetime physical activity and prostate cancer incidence and mortality http://feeds.nature.com/~r/bjc/rss/aop/~3/bRlPIASQqIU/sj.bjc.6605404 A prospective study of lifetime physical activity and prostate cancer incidence and mortality

British Journal of Cancer advance online publication, October 27, 2009. doi:10.1038/sj.bjc.6605404

Authors: N Orsini, R Bellocco, M Bottai, M Pagano, S-O Andersson, J-E Johansson, E Giovannucci & A Wolk

]]> A prospective study of lifetime physical activity and prostate cancer incidence and mortality N Orsini R Bellocco M Bottai M Pagano S-O Andersson J-E Johansson E Giovannucci A Wolk doi:10.1038/sj.bjc.6605404 British Journal of Cancer advance online publication, October 27, 2009 2009-10-27 British Journal of Cancer October 27, 2009 10.1038/sj.bjc.6605404 http://dx.doi.org/10.1038/sj.bjc.6605404 aop current http://dx.doi.org/10.1038/sj.bjc.6605404 Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways http://feeds.nature.com/~r/bjc/rss/aop/~3/lE2Sh1pcWFE/sj.bjc.6605405 Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605405

Authors: A-M Cleton-Jansen, J K Anninga, I H Briaire-de Bruijn, S Romeo, J Oosting, R M Egeler, H Gelderblom, A H M Taminiau & P C W Hogendoorn

]]> Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways A-M Cleton-Jansen J K Anninga I H Briaire-de Bruijn S Romeo J Oosting R M Egeler H Gelderblom A H M Taminiau P C W Hogendoorn doi:10.1038/sj.bjc.6605405 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605405 http://dx.doi.org/10.1038/sj.bjc.6605405 aop current http://dx.doi.org/10.1038/sj.bjc.6605405 Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells http://feeds.nature.com/~r/bjc/rss/aop/~3/wT2VF3JFSA0/sj.bjc.6605406 Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605406

Authors: N Yokota, S Koizume, E Miyagi, F Hirahara, Y Nakamura, K Kikuchi, W Ruf, Y Sakuma, E Tsuchiya & Y Miyagi

]]> Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells N Yokota S Koizume E Miyagi F Hirahara Y Nakamura K Kikuchi W Ruf Y Sakuma E Tsuchiya Y Miyagi doi:10.1038/sj.bjc.6605406 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605406 http://dx.doi.org/10.1038/sj.bjc.6605406 aop current http://dx.doi.org/10.1038/sj.bjc.6605406 Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells http://feeds.nature.com/~r/bjc/rss/aop/~3/G6mKu1aJp1M/sj.bjc.6605407 Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605407

Authors: M Hirotsu, T Setoguchi, Y Matsunoshita, H Sasaki, H Nagao, H Gao, K Sugimura & S Komiya

]]> Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells M Hirotsu T Setoguchi Y Matsunoshita H Sasaki H Nagao H Gao K Sugimura S Komiya doi:10.1038/sj.bjc.6605407 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605407 http://dx.doi.org/10.1038/sj.bjc.6605407 aop current http://dx.doi.org/10.1038/sj.bjc.6605407 Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array http://feeds.nature.com/~r/bjc/rss/aop/~3/6TKA6JgY-CQ/sj.bjc.6605409 Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605409

Authors: J L Perez-Gracia, C Prior, F Guillén-Grima, V Segura, A Gonzalez, A Panizo, I Melero, E Grande-Pulido, A Gurpide, I Gil-Bazo & A Calvo

]]> Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array J L Perez-Gracia C Prior F Guillén-Grima V Segura A Gonzalez A Panizo I Melero E Grande-Pulido A Gurpide I Gil-Bazo A Calvo doi:10.1038/sj.bjc.6605409 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605409 http://dx.doi.org/10.1038/sj.bjc.6605409 aop current http://dx.doi.org/10.1038/sj.bjc.6605409 Geographical and temporal distribution of cancer survival in teenagers and young adults in England http://feeds.nature.com/~r/bjc/rss/aop/~3/FXJdDzbPIoc/sj.bjc.6605410 Geographical and temporal distribution of cancer survival in teenagers and young adults in England

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605410

Authors: M Geraci, T O B Eden, R D Alston, A Moran, R S Arora & J M Birch

]]> Geographical and temporal distribution of cancer survival in teenagers and young adults in England M Geraci T O B Eden R D Alston A Moran R S Arora J M Birch doi:10.1038/sj.bjc.6605410 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605410 http://dx.doi.org/10.1038/sj.bjc.6605410 aop current http://dx.doi.org/10.1038/sj.bjc.6605410 Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma http://feeds.nature.com/~r/bjc/rss/aop/~3/LFK38JpL-OU/sj.bjc.6605411 Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605411

Authors: D A Reardon, G Dresemann, S Taillibert, M Campone, M van den Bent, P Clement, E Blomquist, L Gordower, H Schultz, J Raizer, P Hau, J Easaw, M Gil, J Tonn, A Gijtenbeek, U Schlegel, P Bergstrom, S Green, A Weir & Z Nikolova

]]> Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastoma D A Reardon G Dresemann S Taillibert M Campone M van den Bent P Clement E Blomquist L Gordower H Schultz J Raizer P Hau J Easaw M Gil J Tonn A Gijtenbeek U Schlegel P Bergstrom S Green A Weir Z Nikolova doi:10.1038/sj.bjc.6605411 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605411 http://dx.doi.org/10.1038/sj.bjc.6605411 aop current http://dx.doi.org/10.1038/sj.bjc.6605411 Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study http://feeds.nature.com/~r/bjc/rss/aop/~3/6SqRO9x77L0/sj.bjc.6605412 Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605412

Authors: D A Reardon, A Desjardins, J J Vredenburgh, S Gururangan, J H Sampson, S Sathornsumetee, R E McLendon, J E Herndon, J E Marcello, J Norfleet, A H Friedman, D D Bigner & H S Friedman

]]> Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study D A Reardon A Desjardins J J Vredenburgh S Gururangan J H Sampson S Sathornsumetee R E McLendon J E Herndon J E Marcello J Norfleet A H Friedman D D Bigner H S Friedman doi:10.1038/sj.bjc.6605412 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605412 http://dx.doi.org/10.1038/sj.bjc.6605412 aop current http://dx.doi.org/10.1038/sj.bjc.6605412 Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients http://feeds.nature.com/~r/bjc/rss/aop/~3/VzKFQZAyxys/sj.bjc.6605413 Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients

British Journal of Cancer advance online publication, November 3, 2009. doi:10.1038/sj.bjc.6605413

Authors: M Mego, U De Giorgi, K Broglio, S Dawood, V Valero, E Andreopoulou, B Handy, J M Reuben & M Cristofanilli

]]> Circulating tumour cells are associated with increased risk of venous thromboembolism in metastatic breast cancer patients M Mego U De Giorgi K Broglio S Dawood V Valero E Andreopoulou B Handy J M Reuben M Cristofanilli doi:10.1038/sj.bjc.6605413 British Journal of Cancer advance online publication, November 3, 2009 200-11-03 British Journal of Cancer November 3, 2009 10.1038/sj.bjc.6605413 http://dx.doi.org/10.1038/sj.bjc.6605413 aop current http://dx.doi.org/10.1038/sj.bjc.6605413 Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/71SeE-Ox778/sj.bjc.6605414 Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605414

Authors: S Tamez, C Norizoe, K Ochiai, D Takahashi, A Shimojima, Y Tsutsumi, N Yanaihara, T Tanaka, A Okamoto & M Urashima

]]> Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer S Tamez C Norizoe K Ochiai D Takahashi A Shimojima Y Tsutsumi N Yanaihara T Tanaka A Okamoto M Urashima doi:10.1038/sj.bjc.6605414 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605414 http://dx.doi.org/10.1038/sj.bjc.6605414 aop current http://dx.doi.org/10.1038/sj.bjc.6605414 Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix http://feeds.nature.com/~r/bjc/rss/aop/~3/uiYGFZn3g5w/sj.bjc.6605415 Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605415

Authors: S B Donaldson, D L Buckley, J P O'Connor, S E Davidson, B M Carrington, A P Jones & C M L West

]]> Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix S B Donaldson D L Buckley J P O'Connor S E Davidson B M Carrington A P Jones C M L West doi:10.1038/sj.bjc.6605415 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605415 http://dx.doi.org/10.1038/sj.bjc.6605415 aop current http://dx.doi.org/10.1038/sj.bjc.6605415 Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) http://feeds.nature.com/~r/bjc/rss/aop/~3/L_-03M_UPqs/sj.bjc.6605416 Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605416

Authors: A Osorio, R L Milne, G Pita, P Peterlongo, T Heikkinen, J Simard, G Chenevix-Trench, A B Spurdle, J Beesley, X Chen, S Healey, S L Neuhausen, Y C Ding, F J Couch, X Wang, N Lindor, S Manoukian, M Barile, A Viel, L Tizzoni, C I Szabo, L Foretova, M Zikan, K Claes, M H Greene, P Mai, G Rennert, F Lejbkowicz, O Barnett-Griness, I L Andrulis, H Ozcelik, N Weerasooriya, A-M Gerdes, M Thomassen, D G Cruger, M A Caligo, E Friedman, B Kaufman, Y Laitman, S Cohen, T Kontorovich, R Gershoni-Baruch, E Dagan, H Jernström, M S Askmalm, B Arver, B Malmer, S M Domchek, K L Nathanson, J Brunet, T Ramón y Cajal, D Yannoukakos, U Hamann, F B L Hogervorst, S Verhoef, EB Gómez García, J T Wijnen, A van den Ouweland, D F Easton, S Peock, M Cook, C T Oliver, D Frost, C Luccarini, D G Evans, F Lalloo, R Eeles, G Pichert, J Cook, S Hodgson, P J Morrison, F Douglas, A K Godwin, O M Sinilnikova, L Barjhoux, D Stoppa-Lyonnet, V Moncoutier, S Giraud, C Cassini, L Olivier-Faivre, F Révillion, J-P Peyrat, D Muller, J-P Fricker, H T Lynch, E M John, S Buys, M Daly, J L Hopper, M B Terry, A Miron, Y Yassin, D Goldgar, C F Singer, D Gschwantler-Kaulich, G Pfeiler, A-C Spiess, Thomas v O Hansen, O T Johannsson, T Kirchhoff, K Offit, K Kosarin, M Piedmonte, G C Rodriguez, K Wakeley, J F Boggess, J Basil, P E Schwartz, S V Blank, A E Toland, M Montagna, C Casella, E N Imyanitov, A Allavena, R K Schmutzler, B Versmold, C Engel, A Meindl, N Ditsch, N Arnold, D Niederacher, H Deißler, B Fiebig, R Varon-Mateeva, D Schaefer, U G Froster, T Caldes, M de la Hoya, L McGuffog, A C Antoniou, H Nevanlinna, P Radice & J Benítez

]]> Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) A Osorio R L Milne G Pita P Peterlongo T Heikkinen J Simard G Chenevix-Trench A B Spurdle J Beesley X Chen S Healey S L Neuhausen Y C Ding F J Couch X Wang N Lindor S Manoukian M Barile A Viel L Tizzoni C I Szabo L Foretova M Zikan K Claes M H Greene P Mai G Rennert F Lejbkowicz O Barnett-Griness I L Andrulis H Ozcelik N Weerasooriya A-M Gerdes M Thomassen D G Cruger M A Caligo E Friedman B Kaufman Y Laitman S Cohen T Kontorovich R Gershoni-Baruch E Dagan H Jernström M S Askmalm B Arver B Malmer S M Domchek K L Nathanson J Brunet T Ramón y Cajal D Yannoukakos U Hamann F B L Hogervorst S Verhoef EB Gómez García J T Wijnen A van den Ouweland D F Easton S Peock M Cook C T Oliver D Frost C Luccarini D G Evans F Lalloo R Eeles G Pichert J Cook S Hodgson P J Morrison F Douglas A K Godwin O M Sinilnikova L Barjhoux D Stoppa-Lyonnet V Moncoutier S Giraud C Cassini L Olivier-Faivre F Révillion J-P Peyrat D Muller J-P Fricker H T Lynch E M John S Buys M Daly J L Hopper M B Terry A Miron Y Yassin D Goldgar C F Singer D Gschwantler-Kaulich G Pfeiler A-C Spiess Thomas v O Hansen O T Johannsson T Kirchhoff K Offit K Kosarin M Piedmonte G C Rodriguez K Wakeley J F Boggess J Basil P E Schwartz S V Blank A E Toland M Montagna C Casella E N Imyanitov A Allavena R K Schmutzler B Versmold C Engel A Meindl N Ditsch N Arnold D Niederacher H Deißler B Fiebig R Varon-Mateeva D Schaefer U G Froster T Caldes M de la Hoya L McGuffog A C Antoniou H Nevanlinna P Radice J Benítez doi:10.1038/sj.bjc.6605416 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605416 http://dx.doi.org/10.1038/sj.bjc.6605416 aop current http://dx.doi.org/10.1038/sj.bjc.6605416 Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib http://feeds.nature.com/~r/bjc/rss/aop/~3/4yO3H1RZKtE/sj.bjc.6605417 Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605417

Authors: G Mickisch, M Gore, B Escudier, G Procopio, S Walzer & M Nuijten

]]> Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-α2a compared with sunitinib G Mickisch M Gore B Escudier G Procopio S Walzer M Nuijten doi:10.1038/sj.bjc.6605417 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605417 http://dx.doi.org/10.1038/sj.bjc.6605417 aop current http://dx.doi.org/10.1038/sj.bjc.6605417 A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC http://feeds.nature.com/~r/bjc/rss/aop/~3/u7zTkZF0WFs/sj.bjc.6605418 A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605418

Authors: E J Dean, T Ward, C Pinilla, R Houghten, K Welsh, G Makin, M Ranson & C Dive

]]> A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC E J Dean T Ward C Pinilla R Houghten K Welsh G Makin M Ranson C Dive doi:10.1038/sj.bjc.6605418 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605418 http://dx.doi.org/10.1038/sj.bjc.6605418 aop current http://dx.doi.org/10.1038/sj.bjc.6605418 Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study http://feeds.nature.com/~r/bjc/rss/aop/~3/v-uIgQxCspo/sj.bjc.6605420 Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605420

Authors: R Wilkowski, S Boeck, S Ostermaier, R Sauer, M Herbst, R Fietkau, M Flentje, S Miethe, H D Boettcher, T Scholten, C J Bruns, H G Rau, A Hinke & V Heinemann

]]> Chemoradiotherapy with concurrent gemcitabine and cisplatin with or without sequential chemotherapy with gemcitabine/cisplatin vs chemoradiotherapy with concurrent 5-fluorouracil in patients with locally advanced pancreatic cancer – a multi-centre randomised phase II study R Wilkowski S Boeck S Ostermaier R Sauer M Herbst R Fietkau M Flentje S Miethe H D Boettcher T Scholten C J Bruns H G Rau A Hinke V Heinemann doi:10.1038/sj.bjc.6605420 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605420 http://dx.doi.org/10.1038/sj.bjc.6605420 aop current http://dx.doi.org/10.1038/sj.bjc.6605420 Age of onset in familial breast cancer as background data for medical surveillance http://feeds.nature.com/~r/bjc/rss/aop/~3/ALg0Q9Fea7Q/sj.bjc.6605421 Age of onset in familial breast cancer as background data for medical surveillance

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605421

Authors: A Brandt, J Lorenzo Bermejo, J Sundquist & K Hemminki

]]> Age of onset in familial breast cancer as background data for medical surveillance A Brandt J Lorenzo Bermejo J Sundquist K Hemminki doi:10.1038/sj.bjc.6605421 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605421 http://dx.doi.org/10.1038/sj.bjc.6605421 aop current http://dx.doi.org/10.1038/sj.bjc.6605421 Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/N9B-tGulI1A/sj.bjc.6605422 Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605422

Authors: E A M Heijnsdijk, A der Kinderen, E M Wever, G Draisma, M J Roobol & H J de Koning

]]> Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer E A M Heijnsdijk A der Kinderen E M Wever G Draisma M J Roobol H J de Koning doi:10.1038/sj.bjc.6605422 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605422 http://dx.doi.org/10.1038/sj.bjc.6605422 aop current http://dx.doi.org/10.1038/sj.bjc.6605422 CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/DElThmYzn2g/sj.bjc.6605423 CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605423

Authors: T van Agthoven, A M Sieuwerts, J Veldscholte, M E Meijer-van Gelder, M Smid, A Brinkman, A T den Dekker, I M Leroy, W F J van IJcken, S Sleijfer, J A Foekens & L C J Dorssers

]]> CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer T van Agthoven A M Sieuwerts J Veldscholte M E Meijer-van Gelder M Smid A Brinkman A T den Dekker I M Leroy W F J van IJcken S Sleijfer J A Foekens L C J Dorssers doi:10.1038/sj.bjc.6605423 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605423 http://dx.doi.org/10.1038/sj.bjc.6605423 aop current http://dx.doi.org/10.1038/sj.bjc.6605423 Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000–2006 http://feeds.nature.com/~r/bjc/rss/aop/~3/daCSMU2fLMw/sj.bjc.6605424 Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000–2006

British Journal of Cancer advance online publication, November 10, 2009. doi:10.1038/sj.bjc.6605424

Authors: L Fairley, M Baker, J Whiteway, W Cross & D Forman

]]> Trends in non-metastatic prostate cancer management in the Northern and Yorkshire region of England, 2000–2006 L Fairley M Baker J Whiteway W Cross D Forman doi:10.1038/sj.bjc.6605424 British Journal of Cancer advance online publication, November 10, 2009 200-11-10 British Journal of Cancer November 10, 2009 10.1038/sj.bjc.6605424 http://dx.doi.org/10.1038/sj.bjc.6605424 aop current http://dx.doi.org/10.1038/sj.bjc.6605424 Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/KWgR11uxS_Y/sj.bjc.6605427 Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605427

Authors: J Dose-Schwarz, R Tiling, S Avril-Sassen, S Mahner, A Lebeau, C Weber, M Schwaiger, F Jänicke, M Untch & N Avril

]]> Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancer J Dose-Schwarz R Tiling S Avril-Sassen S Mahner A Lebeau C Weber M Schwaiger F Jänicke M Untch N Avril doi:10.1038/sj.bjc.6605427 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605427 http://dx.doi.org/10.1038/sj.bjc.6605427 aop current http://dx.doi.org/10.1038/sj.bjc.6605427 Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/gfsuYWCHFWI/sj.bjc.6605432 Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605432

Authors: T Yoshioka, S Kato, M Gamoh, N Chiba, T Suzuki, N Sakayori, S Kato, H Shibata, H Shimodaira, K Otsuka, Y Kakudo, S Takahashi & C Ishioka

]]> Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer T Yoshioka S Kato M Gamoh N Chiba T Suzuki N Sakayori S Kato H Shibata H Shimodaira K Otsuka Y Kakudo S Takahashi C Ishioka doi:10.1038/sj.bjc.6605432 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605432 http://dx.doi.org/10.1038/sj.bjc.6605432 aop current http://dx.doi.org/10.1038/sj.bjc.6605432 Relation of risk of contralateral breast cancer to the interval since the first primary tumour http://feeds.nature.com/~r/bjc/rss/aop/~3/cMNfZ75sW0o/sj.bjc.6605434 Relation of risk of contralateral breast cancer to the interval since the first primary tumour

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605434

Authors: C Rubino, R Arriagada, S Delaloge & M G Lê

]]> Relation of risk of contralateral breast cancer to the interval since the first primary tumour C Rubino R Arriagada S Delaloge M G Lê doi:10.1038/sj.bjc.6605434 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605434 http://dx.doi.org/10.1038/sj.bjc.6605434 aop current http://dx.doi.org/10.1038/sj.bjc.6605434 In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring http://feeds.nature.com/~r/bjc/rss/aop/~3/OIEiSHZGBqE/sj.bjc.6605436 In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605436

Authors: W Zhong, J P Celli, I Rizvi, Z Mai, B Q Spring, S H Yun & T Hasan

]]> In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring W Zhong J P Celli I Rizvi Z Mai B Q Spring S H Yun T Hasan doi:10.1038/sj.bjc.6605436 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605436 http://dx.doi.org/10.1038/sj.bjc.6605436 aop current http://dx.doi.org/10.1038/sj.bjc.6605436 Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma http://feeds.nature.com/~r/bjc/rss/aop/~3/3ZwiBnZ1zt4/sj.bjc.6605437 Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605437

Authors: V Bilim, A Ougolkov, K Yuuki, S Naito, H Kawazoe, A Muto, M Oya, D Billadeau, T Motoyama & Y Tomita

]]> Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma V Bilim A Ougolkov K Yuuki S Naito H Kawazoe A Muto M Oya D Billadeau T Motoyama Y Tomita doi:10.1038/sj.bjc.6605437 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605437 http://dx.doi.org/10.1038/sj.bjc.6605437 aop current http://dx.doi.org/10.1038/sj.bjc.6605437 Epac inhibits migration and proliferation of human prostate carcinoma cells http://feeds.nature.com/~r/bjc/rss/aop/~3/ND7xxXw9wPg/sj.bjc.6605439 Epac inhibits migration and proliferation of human prostate carcinoma cells

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605439

Authors: M Grandoch, A Rose, M ter Braak, V Jendrossek, H Rübben, J W Fischer, M Schmidt & A A Weber

]]> Epac inhibits migration and proliferation of human prostate carcinoma cells M Grandoch A Rose M ter Braak V Jendrossek H Rübben J W Fischer M Schmidt A A Weber doi:10.1038/sj.bjc.6605439 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605439 http://dx.doi.org/10.1038/sj.bjc.6605439 aop current http://dx.doi.org/10.1038/sj.bjc.6605439 Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression http://feeds.nature.com/~r/bjc/rss/aop/~3/ACzsKTUryCc/sj.bjc.6605440 Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605440

Authors: G Chen, X Tian, Z Liu, S Zhou, B Schmidt, D Henne-Bruns, M Bachem & M Kornmann

]]> Inhibition of endogenous SPARC enhances pancreatic cancer cell growth: modulation by FGFR1-III isoform expression G Chen X Tian Z Liu S Zhou B Schmidt D Henne-Bruns M Bachem M Kornmann doi:10.1038/sj.bjc.6605440 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605440 http://dx.doi.org/10.1038/sj.bjc.6605440 aop current http://dx.doi.org/10.1038/sj.bjc.6605440 Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial http://feeds.nature.com/~r/bjc/rss/aop/~3/WUfuo0R_yew/sj.bjc.6605441 Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605441

Authors: P Bougnoux, N Hajjaji, M N Ferrasson, B Giraudeau, C Couet & O Le Floch

]]> Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial P Bougnoux N Hajjaji M N Ferrasson B Giraudeau C Couet O Le Floch doi:10.1038/sj.bjc.6605441 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605441 http://dx.doi.org/10.1038/sj.bjc.6605441 aop current http://dx.doi.org/10.1038/sj.bjc.6605441 Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer http://feeds.nature.com/~r/bjc/rss/aop/~3/3M-QRcgQlmA/sj.bjc.6605442 Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605442

Authors: T Conroy, M Hebbar, J Bennouna, M Ducreux, M Ychou, G Llédo, A Adenis, R Faroux, C Rebischung, L Kockler & J Y Douillard

]]> Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer T Conroy M Hebbar J Bennouna M Ducreux M Ychou G Llédo A Adenis R Faroux C Rebischung L Kockler J Y Douillard doi:10.1038/sj.bjc.6605442 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605442 http://dx.doi.org/10.1038/sj.bjc.6605442 aop current http://dx.doi.org/10.1038/sj.bjc.6605442 A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma http://feeds.nature.com/~r/bjc/rss/aop/~3/uasms5SVXt4/sj.bjc.6605443 A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605443

Authors: R Marcus, R Aultman & F Jost

]]> A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma R Marcus R Aultman F Jost doi:10.1038/sj.bjc.6605443 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605443 http://dx.doi.org/10.1038/sj.bjc.6605443 aop current http://dx.doi.org/10.1038/sj.bjc.6605443 Evolutionary game theory: lessons and limitations, a cancer perspective http://feeds.nature.com/~r/bjc/rss/aop/~3/6WNMx4fAe9I/sj.bjc.6605444 Evolutionary game theory: lessons and limitations, a cancer perspective

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605444

Author: J W McEvoy

]]> Evolutionary game theory: lessons and limitations, a cancer perspective J W McEvoy doi:10.1038/sj.bjc.6605444 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605444 http://dx.doi.org/10.1038/sj.bjc.6605444 aop current http://dx.doi.org/10.1038/sj.bjc.6605444 Reply: Evolutionary game theory: lessons and limitations, a cancer perspective http://feeds.nature.com/~r/bjc/rss/aop/~3/5UPOYmI4yqo/sj.bjc.6605445 Reply: Evolutionary game theory: lessons and limitations, a cancer perspective

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605445

Authors: D Dingli, F A C C Chalub, F C Santos, S Van Segbroeck & J M Pacheco

]]> Reply: Evolutionary game theory: lessons and limitations, a cancer perspective D Dingli F A C C Chalub F C Santos S Van Segbroeck J M Pacheco doi:10.1038/sj.bjc.6605445 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605445 http://dx.doi.org/10.1038/sj.bjc.6605445 aop current http://dx.doi.org/10.1038/sj.bjc.6605445 In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma http://feeds.nature.com/~r/bjc/rss/aop/~3/h233sLw3xxE/sj.bjc.6605448 In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma

British Journal of Cancer advance online publication, November 17, 2009. doi:10.1038/sj.bjc.6605448

Authors: K El-Sahwi, S Bellone, E Cocco, M Cargnelutti, F Casagrande, M Bellone, M Abu-Khalaf, N Buza, F A Tavassoli, P Hui, D-A Silasi, M Azodi, P E Schwartz, T J Rutherford, S Pecorelli & A D Santin

]]> In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenocarcinoma K El-Sahwi S Bellone E Cocco M Cargnelutti F Casagrande M Bellone M Abu-Khalaf N Buza F A Tavassoli P Hui D-A Silasi M Azodi P E Schwartz T J Rutherford S Pecorelli A D Santin doi:10.1038/sj.bjc.6605448 British Journal of Cancer advance online publication, November 17, 2009 200-11-17 British Journal of Cancer November 17, 2009 10.1038/sj.bjc.6605448 http://dx.doi.org/10.1038/sj.bjc.6605448 aop current http://dx.doi.org/10.1038/sj.bjc.6605448